Identification of five clusters of comorbidities in a longitudinal Japanese chronic obstructive pulmonary disease cohort

Respiratory Medicine

Volumn 117, Issue , 2016, Pages 272-279

  Chubachi, Shotaro ^a   Sato, Minako ^a   Kameyama, Naofumi ^a   Tsutsumi, Akihiro ^a   Sasaki, Mamoru ^a   Tateno, Hiroki ^a   Nakamura, Hidetoshi ^a,b   Asano, Koichiro ^c   Betsuyaku, Tomoko ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic obstructive pulmonary disease; Cluster analysis; Comorbidity; Phenotype; Quality of life

Indexed keywords

AGED; ANEMIA; ANXIETY DISORDER; ARTICLE; BRAIN INFARCTION; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLUSTER ANALYSIS; COHORT ANALYSIS; COMORBIDITY; COPD ASSESSMENT TEST; CORONARY ARTERY DISEASE; DEPRESSION; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; HEART FAILURE; HUMAN; HYPERTENSION; HYPERURICEMIA; LONGITUDINAL STUDY; LUNG CANCER; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MENTAL DISEASE; METABOLIC DISORDER; OBESITY; OSTEOPOROSIS; PEPTIC ULCER; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; RESPIRATORY TRACT DISEASE ASSESSMENT; ST. GEORGE RESPIRATORY QUESTIONNAIRE; UNDERWEIGHT; COMPLICATION; DIAGNOSTIC IMAGING; JAPAN; NEOPLASM; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; SELF REPORT; SMOKING; TRENDS; VERY ELDERLY; X-RAY COMPUTED TOMOGRAPHY;

AGED; AGED, 80 AND OVER; ANEMIA; CARDIOVASCULAR DISEASES; CLUSTER ANALYSIS; COHORT STUDIES; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; HUMANS; JAPAN; LONGITUDINAL STUDIES; MALE; NEOPLASMS; PHENOTYPE; PROSPECTIVE STUDIES; PULMONARY DIFFUSING CAPACITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SELF REPORT; SMOKING; THINNESS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84978269121     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2016.07.002     Document Type: Article

References (44)

1. [1] Barnes, P.J., Celli, B.R., Systemic manifestations and comorbidities of COPD. Eur. Respir. J. 33 (2009), 1165–1185.
2. [2] van Manen, J.G., Bindels, P.J., Dekker, E.W., Ijzermans, C.J., Bottema, B.J., van der Zee, J.S., Schadé, E., Added value of co-morbidity in predicting health-related quality of life in COPD patients. Respir. Med. 95 (2001), 496–504.
3. [3] Holguin, F., Folch, E., Redd, S.C., Mannino, D.M., Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest. 128 (2005), 2005–2011.
4. [4] Antonelli Incalzi, R., Fuso, L., De Rosa, M., Forastiere, F., Rapiti, E., Nardecchia, B., Pistelli, R., Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur. Respir. J. 10 (1997), 2794–2800.
5. [5] Burgel, P.R., Paillasseur, J.L., Caillaud, D., Tillie-Leblond, I., Chanez, P., Escamilla, R., Court-Fortune, I., Perez, T., Carré, P., Roche, N., Initiatives BPCO Scientific Committee. Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur. Respir. J. 36 (2010), 531–539.
6. [6] Rennard, S.I., Locantore, N., Delafont, B., Tal-Singer, R., Silverman, E.K., Vestbo, J., Miller, B.E., Bakke, P., Celli, B., Calverley, P.M., Coxson, H., Crim, C., Edwards, L.D., Lomas, D.A., MacNee, W., Wouters, E.F., Yates, J.C., Coca, I., Agustí, A., Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints. Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis. Ann. Am. Thorac. Soc. 12 (2015), 303–312.
7. [7] Garcia-Aymerich, J., Gómez, F.P., Benet, M., Farrero, E., Basagaña, X., Gayete, À., Paré, C., Freixa, X., Ferrer, J., Ferrer, A., Roca, J., Gáldiz, J.B., Sauleda, J., Monsó, E., Gea, J., Barberà, J.A., Agustí, À., Antó, J.M., PAC-COPD Study Group. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax 66 (2011), 430–437.
8. [8] Vanfleteren, L.E., Spruit, M.A., Groenen, M., Gaffron, S., van Empel, V.P., Bruijnzeel, P.L., Rutten, E.P., Op ’t Roodt, J., Wouters, E.F., Franssen, F.M., Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 187 (2013), 728–735.
9. [9] Miyazaki, M., Nakamura, H., Chubachi, S., Sasaki, M., Haraguchi, M., Yoshida, S., Tsuduki, K., Shirahata, T., Takahashi, S., Minematsu, N., Koh, H., Nakamura, M., Sakamaki, F., Terashima, T., Sayama, K., Jones, P.W., Asano, K., Betsuyaku, T., Keio COPD Comorbidity Research (K-CCR) Group. Analysis of comorbid factors that increase the COPD assessment test scores. Respir. Res., 15, 2014, 13.
10. [10] Chubachi, S., Nakamura, H., Sasaki, M., Haraguchi, M., Miyazaki, M., Takahashi, S., Tanaka, K., Funatsu, Y., Asano, K., Betsuyaku, T., Keio COPD Comorbidity Research (K-CCR) Group. Polymorphism of LRP5 gene and emphysema severity are associated with osteoporosis in Japanese patients with or at risk for COPD. Respirology 20 (2015), 286–295.
11. [11] Miyazaki, M., Nakamura, H., Takahashi, S., Chubachi, S., Sasaki, M., Haraguchi, M., Terai, H., Ishii, M., Fukunaga, K., Tasaka, S., Soejima, K., Asano, K., Betsuyaku, T., Keio COPD Comorbidity Research (K-CCR) group. The reasons for triple therapy in stable COPD patients in Japanese clinical practice. Int. J. Chron. Obstruct Pulmon Dis. 10 (2015), 1053–1059.
12. [12] Haraguchi, M., Nakamura, H., Sasaki, M., Miyazaki, M., Chubachi, S., Takahashi, S., Asano, K., Jones, P.W., Betsuyaku, T., Keio COPD Comorbidity Research (K-CCR) Group. Determinants of chronic obstructive pulmonary disease severity in the late-elderly differ from those in younger patients. BMC Res. Notes, 9, 2016, 7.
13. [13] Takahashi, S., Betsuyaku, T., The chronic obstructive pulmonary disease comorbidity spectrum in Japan differs from that in western countries. Respir. Investig. 53:2 (2015), 59–70.
14. [14] Divo, M., Cote, C., de Torres, J.P., Casanova, C., Marin, J.M., Pinto-Plata, V., Zulueta, J., Cabrera, C., Zagaceta, J., Hunninghake, G., Celli, B., BODE Collaborative Group. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 186 (2012), 155–161.
15. [15] Siebeling, L., Puhan, M.A., Muggensturm, P., Zoller, M., Ter Riet, G., Characteristics of Dutch and Swiss primary care COPD patients - baseline data of the ICE COLD ERIC study. Clin. Epidemiol. 3 (2011), 273–283.
16. [16] Hajiro, T., Nishimura, K., Tsukino, M., Ikeda, A., Koyama, H., Izumi, T., Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 157 (1998), 785–790.
17. [17] Hajiro, T., Nishimura, K., Tsukino, M., Ikeda, A., Koyama, H., Izumi, T., Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 158 (1998), 1185–1189.
18. [18] Jones, P.W., Quirk, F.H., Baveystock, C.M., Littlejohns, P., A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am. Rev. Respir. Dis. 145 (1992), 1321–1327.
19. [19] Kwon, N., Amin, M., Hui, D.S., Jung, K.S., Lim, S.Y., Ta, H.D., Thai, T.T., Jones, P.W., Validity of the COPD assessment test translated into local languages for Asian patients. Chest 143 (2013), 703–710.
20. [20] Jones, P.W., Harding, G., Berry, P., Wiklund, I., Chen, W.H., Kline Leidy, N., Development and first validation of the COPD assessment test. Eur. Respir. J. 34 (2009), 648–654.
21. [21] Fukuhara, S., Bito, S., Green, J., Hsiao, A., Kurokawa, K., Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J. Clin. Epidemiol. 51 (1998), 1037–1044.
22. [22] McGarvey, L.P., John, M., Anderson, J.A., Zvarich, M., Wise, R.A., TORCH clinical endpoint committee. Ascertainment of cause-specific mortality in COPD: operations of the TORCH clinical endpoint committee. Thorax. 62 (2007), 411–415.
23. [23] Crisafulli, E., Costi, S., Luppi, F., Cirelli, G., Cilione, C., Coletti, O., Fabbri, L.M., Clini, E.M., Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation. Thorax. 63 (2008), 487–492.
24. [24] Kusano, M., Shimoyama, Y., Sugimoto, S., Kawamura, O., Maeda, M., Minashi, K., Kuribayashi, S., Higuchi, T., Zai, H., Ino, K., Horikoshi, T., Sugiyama, T., Toki, M., Ohwada, T., Mori, M., J. Gastroenterol. 39 (2004), 888–891.
25. [25] Zigmond, A.S., Snaith, R.P., The hospital anxiety and depression scale. Acta Psychiatr. Scand. 67 (1983), 361–370.
26. [26] Celli, B.R., Cote, C.G., Marin, J.M., Casanova, C., Montes de Oca, M., Mendez, R.A., Pinto Plata, V., Cabral, H.J., The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N. Engl. J. Med. 350 (2004), 1005–1012.
27. [27] Blanc, B., Finch, C., Hallberg, L., Nutritional anaemias. Report of a WHO scientific group. WHO Tech. Rep. Ser., 1968, 1–40.
28. [28] Barrett-Connor, E., Black, D., Bonjour, J.P., Dequeker, J., Ehrlich, G.E., Eis, S.R., Genant, H.K., Gennari, C., Johnell, O., Kanis, J., et al. Prevention and management of osteoporosis. World Health Organ. Tech. Rep. Ser. 921 (2003), 1–164.
29. [29] WHO Expert Consultation, Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 363 (2004), 157–163.
30. [30] McLachlan, G.J., Cluster analysis and related techniques in medical research. Stat. Methods Med. Res. 1 (1992), 27–48.
31. [31] Ye, W., Robbins, R.T., Cluster analysis of longidorus species (nematoda: longidoridae), a new approach in species identification. J. Nematol. 36 (2004), 207–219.
32. [32] Raudenbush, S.W., Bryk, A.S., Hierarchical Linear Models. 2002, Sage, Newbury Park, NJ.
33. [33] Shibata, Y., Inoue, S., Igarashi, A., Yamauchi, K., Abe, S., Aida, Y., Nunomiya, K., Sato, M., Nakano, H., Sato, K., Nemoto, T., Kimura, T., Watanabe, T., Konta, T., Daimon, M., Ueno, Y., Kato, T., Kayama, T., Kubota, I., A lower level of forced expiratory volume in 1 second is a risk factor for all-cause and cardiovascular mortality in a Japanese population: the Takahata study. PLoS One, 8, 2013, e83725.
34. [34] Fukuchi, Y., Fernandez, L., Kuo, H.P., Mahayiddin, A., Celli, B., Decramer, M., Kesten, S., Liu, D., Tashkin, D., Efficacy of tiotropium in COPD patients from Asia: a subgroup analysis from the UPLIFT trial. Respirology. 16 (2011), 825–835.
35. [35] Sin, D.D., Anthonisen, N.R., Soriano, J.B., Agusti, A.G., Mortality in COPD: role of comorbidities. Eur. Respir. J. 28 (2006), 1245–1257.
36. [36] Anthonisen, N.R., Skeans, M.A., Wise, R.A., Manfreda, J., Kanner, R.E., Connett, J.E., Lung Health Study Research Group. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann. Intern Med. 142 (2005), 233–239.
37. [37] Vestbo, J., Anderson, W., Coxson, H.O., Crim, C., Dawber, F., Edwards, L., Hagan, G., Knobil, K., Lomas, D.A., MacNee, W., Silverman, E.K., Tal-Singer, R., ECLIPSE investigators. Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE). Eur. Respir. J. 31 (2008), 869–873.
38. [38] Sekine, Y., Katsura, H., Koh, E., Hiroshima, K., Fujisawa, T., Early detection of COPD is important for lung cancer surveillance. Eur. Respir. J. 39 (2012), 1230–1240.
39. [39] Anthonisen, N.R., Connett, J.E., Enright, P.L., Manfreda, J., Lung health study research group. Hospitalizations and mortality in the lung health study. Am. J. Respir. Crit. Care Med. 166 (2002), 333–339.
40. [40] Agudo, A., Bonet, C., Travier, N., González, C.A., Vineis, P., Bueno-de-Mesquita, H.B., Trichopoulos, D., Boffetta, P., Clavel-Chapelon, F., Boutron-Ruault, M.C., Kaaks, R., Lukanova, A., Schütze, M., Boeing, H., Tjonneland, A., Halkjaer, J., Overvad, K., Dahm, C.C., Quirós, J.R., Sánchez, M.J., Larrañaga, N., Navarro, C., Ardanaz, E., Khaw, K.T., Wareham, N.J., Key, T.J., Allen, N.E., Trichopoulou, A., Lagiou, P., Palli, D., Sieri, S., Tumino, R., Panico, S., Boshuizen, H., Büchner, F.L., Peeters, P.H., Borgquist, S., Almquist, M., Hallmans, G., Johansson, I., Gram, I.T., Lund, E., Weiderpass, E., Romieu, I., Riboli, E., J. Clin. Oncol. 30 (2012), 4550–4557.
41. [41] Gu, D., Kelly, T.N., Wu, X., Chen, J., Samet, J.M., Huang, J.F., Zhu, M., Chen, J.C., Chen, C.S., Duan, X., Klag, M.J., He, J., N. Engl. J. Med. 360 (2009), 150–159.
42. [42] Burgel, P.R., Escamilla, R., Perez, T., Carré, P., Caillaud, D., Chanez, P., Pinet, C., Jebrak, G., Brinchault, G., Court-Fortune, I., Paillasseur, J.L., Roche, N., INITIATIVES BPCO Scientific Committee. Impact of comorbidities on COPD-specific health-related quality of life. Respir. Med. 107 (2013), 233–241.
43. [43] Bolton, C.E., Ionescu, A.A., Shiels, K.M., Pettit, R.J., Edwards, P.H., Stone, M.D., Nixon, L.S., Evans, W.D., Griffiths, T.L., Shale, D.J., Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 170 (2004), 1286–1293.
44. [44] United Nations Department of Economic and Social Affairs Population Division, World Population Prospects: the 2010 Revision, Volume I Comprehensive Tables. 2011 http://esa.un.org/wpp/documentation/pdf/WPP2010_Volume-I_Comprehensive-Tables.pdf.